Four leading healthcare academics in Oxford have received a prestigious national award. The University of Oxford professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”. The successful candidates are all prominent researchers in the NIHR Oxford Biomedical Research Centre … Read more
News for Vaccines and Endemic Diseases
HIV remission achieved in second patient
A second person has experienced sustained remission from HIV-1 after ceasing treatment, ten years after the first such case. The case was reported in a paper to be published in Nature. Like the first such case, known as the ‘Berlin Patient’, the second patient was treated with stem cell transplants from donors carrying a genetic … Read more
Oxford medical researchers win prestigious national awards
Leading health researchers in Oxford have been recognised in a prestigious national competition. Eight professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”. The successful candidates are all prominent researchers in the NIHR Oxford Biomedical Research Centre … Read more
World-first NHS trial for universal flu vaccine
The world’s first widespread human testing of a flu vaccine which NIHR Oxford BRC researchers hope will protect more over 65-year-olds against influenza has begun in the NHS. More than 10,000 people aged 65 and over will be asked to take part in a study supported by the National Institute for Health Research (NIHR) and … Read more
New typhoid vaccine offers hope of protection for children globally
A new conjugate vaccine against typhoid has been proven in trials in Oxford to be safe and effective in preventing the disease, and can be used to protect both adults and children. A study published in The Lancet is the first clinical trial to show that immunisation with a new vaccine called Vi-TT is safe, … Read more
Pregnant women to help test vaccine against childhood virus
Pregnant women receiving antenatal care in the Women’s Centre at Oxford’s John Radcliffe Hospital (JR) may be asked to take part in a world-first clinical trial to find a vaccine against a common and potentially serious viral infection in babies. Women are being asked if they would like to take part in a research trial … Read more
BRC researcher honoured for Africa radio project
A researcher supported by the NIHR Oxford Biomedical Researcher has been recognised by the University of Oxford for work to communicate with children in Africa about the Ebola outbreak. Dr Matthew Snape was one of 12 winners in the inaugural Vice-Chancellor’s Awards for Public Engagement with Research. Dr Snape, of the University’s Oxford Vaccine Group, … Read more
Data debate video and podcast now online
A video of an hour-long debate on issues around mass sharing of patient data to support research and improve patient care can now be viewed online. “Good to share? Data, research, privacy and the NHS” was held as part of the NIHR Oxford Biomedical Research Centre’s Public Open Day – Celebrating Biomedical Research on April … Read more
Prostate cancer vaccine trial seeks volunteers
Oxford University scientists have started a clinical trial to test a new vaccine against prostate cancer and are looking for volunteers to take part. The first four participants have already received this experimental vaccine at the Churchill Hospital in Oxford, and the second trial site has just been opened at the Royal Hallamshire Hospital in … Read more
Volunteers sought for childhood infection vaccine study
Oxford University researchers are looking for healthy adults to take part in the initial BRC-supported trial of a potential new vaccine against a virus considered to be a crucial missing element in the childhood vaccination programme. Respiratory syncytial virus (RSV) kills around 200,000 people worldwide each year. Both the elderly and infants are especially vulnerable … Read more